Korea News
-
Korea's GenKOre inks $300 M deal with US to develop in vivo gene-editing therapies
Korea | News | 0 Comment | 26 Jan, 2023
GenKOre, Inc., a Korea-based biotech company with hypercompact CRISPR-Cas tools, has entered into a ...Read more
-
Korea's International Vaccine Institute opens Country Office in Austria
Korea | News | 0 Comment | 25 Jan, 2023
The International Vaccine Institute (IVI), based in Seoul (South Korea) has launched an IVI Country Office in&...Read more
-
Lotte Biologics announces $3 B investment plan to leap forward as global CDMO
Korea | News | 0 Comment | 24 Jan, 2023
Lotte Biologics CEO Richard Won-jik Lee has announced a blueprint to leap forward as a global contract development and m...Read more
-
Korea gives fast track approval to promising DNA vaccine for advanced cervical cancer
Korea | News | 0 Comment | 23 Jan, 2023
Genexine, a clinical-staged Korean biopharmaceutical company committed to the discovery and development of novel biologi...Read more
-
SK Bioscience accelerates global growth strategy by picking talent from Big Pharma
Korea | News | 0 Comment | 23 Jan, 2023
South Korea-based SK bioscience has announced that Richard Kensinger, PhD (Left), former Director and Head of Drug Subst...Read more
-
South Korea's NGeneBio expands to ASEAN precision diagnosis market
Korea | News | 0 Comment | 20 Jan, 2023
South Korean diagnostics company NGeneBio Co. is accelerating its expansion into the ASEAN precision diagnosis market. ...Read more
-
South Korea approves Novavax Nuvaxovid COVID-19 vaccine as adult booster
Korea | News | 0 Comment | 19 Jan, 2023
US-based Novavax, Inc. has announced that partner SK bioscience, based in South Korea, has received expanded manufacturi...Read more
-
Korea provides new equation to US FDA for improving drug interaction prediction
Korea | News | 0 Comment | 18 Jan, 2023
Since it is practically impossible to evaluate all interactions between new drug candidates and all marketed drugs durin...Read more
-
Japan's Toray rolls out Remitch tablets for Pruritus treatment in Korea
Korea | News | 0 Comment | 17 Jan, 2023
Japan-based Toray Industries, Inc., has announced that Korean marketing partner SK Chemicals Co. has begun selling REMIT...Read more
-
New partnerships in Korea to transform mRNA technology into more vaccines
Korea | News | 0 Comment | 16 Jan, 2023
Gachon University, the Korea mRNA Vaccine Initiative (KmVAC), and the International Vaccine Institute (IVI) recently exc...Read more
-
Korea | News | 0 Comment | 13 Jan, 2023
Celltrion Healthcare, a South Korean biopharmaceutical company specialising in the development and production of biosimi...Read more
-
Southern Star Research announces expansion into South Korea and Singapore
Korea | News | 0 Comment | 12 Jan, 2023
Southern Star Research, an Australian contract research organisation (CRO) specialising in clinical trial acceleration w...Read more
-
IVI, Batavia Biosciences sign MoU for vaccine research and development
Korea | News | 0 Comment | 10 Jan, 2023
The International Vaccine Institute (IVI), a South Korea-based international organisation devoted to vaccines for global...Read more
-
Lunit provides AI-based chest X-Ray solution to Latin America's largest hospital
Korea | News | 0 Comment | 09 Jan, 2023
South Korea-based startup Lunit has signed a software license agreement with the Hospital Israelita Albert Einstein in S...Read more
-
South Korea's Alteogen partners with Sandoz AG for biosimilars
Korea | News | 0 Comment | 04 Jan, 2023
South Korean firm Alteogen Inc has entered into an exclusive license agreement with Sandoz AG. Under the terms of t...Read more
-
Korea | News | 0 Comment | 30 Dec, 2022
South Korea-based LifeSemantics has launched Redpill Breath, a digital therapeutics (DTx) for patients requiri...Read more
-
South Korea's EOFlow takes wearable insulin patch to US market
Korea | News | 0 Comment | 28 Dec, 2022
EOFlow, a provider of wearable drug delivery systems (DDS), has announced that it has submitted a 510(k) application to ...Read more
-
Korean firm LegoChem Biosciences inks $1.25 B research collaboration with Amgen
Korea | News | 0 Comment | 26 Dec, 2022
South Korea-based LegoChem Biosciences, Inc. (LCB) has entered into a research collaboration and license agree...Read more
